Direct consumer promotion of prescription drugs: A review of the literature and the New Zealand experience

Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing

Volumn 2, Issue 4, 2002, Pages 293-310

  Eagle, Lynne ^a   Kitchen, Philip ^b  

^a Massey University at Albany ^*

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

advertising; pharmaceutical; physician patient relationships; promotion

Indexed keywords

EID: 84990317334     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/palgrave.jmm.5040088     Document Type: Article

References (104)

1. Medicines Act (1981) Government Printer, Wellington, New Zealand.
2. New Zealand Bill of Rights Act (1990) Government Printer, Wellington, New Zealand.
3. MacKay P. (2000) ‘Pharmaceutical advertising – as seen on TV’, New Zealand Medical Association Newsletter, Issue 236, 12 May, 1–2.
4. Researched Medicines Industry (RMI) (2000) DTC Advertising Can Enhance Public Health, http://www.nzhealthco.nz/rmi, accessed 7/9/2000.
5. MacKay P. DTC Advertising Can Enhance Public Health.
6. Johnson G. L. Ramaprasad A. (2000) ‘Patient-physician relationships in the information age’, Marketing Health Services, Spring, 21–7.
7. Anonymous (1999) ‘AMA accepts the inevitable: DTC ads are here to stay’, Medical Marketing and Media, August, 28.
8. Thornton J. (2000) ‘Should drug ads be legal?’. Marketing, 4 May, 28–9.
9. Anonymous (1998) ‘Doctor, doctor. Let advertisers tell Europe's patients more about drugs’, The Economist, 8 August, 18.
10. Thornton J. The Economist.
11. Anonymous (1998) The Economist.
12. Researched Medicines Industry (RMI) The Economist.
13. Wang J. C. (1999) ‘Beyond DTC: What to do if FDA scales back DTC advertising’, Pharmaceutical Executive, July, 58-60.
14. Medicines Act (1981) Pharmaceutical Executive.
15. Medicines Regulations (1984) Government Printer, Wellington, New Zealand.
16. Advertising Standards Association (ASA) (2000a) Codes of Practice – Code for Therapeutic Advertising, http://www.asa.co.nz, accessed 7/9/2000.
17. Fair Trading Act (1986) Government Printer, Wellington, New Zealand.
18. Consumer Guarantees Act (1993) Government Printer, Wellington, New Zealand.
19. New Zealand Bill of Rights Act (1990) Pharmaceutical Executive.
20. Gray J. (1992) ‘Advertising bans: administrative decisions or matters of principle?’. Centre for Independent Studies, Occasional Paper No. 42.
21. Fisher S. (1999) ‘The impact of parallel importing on consumer law’, Bachelor of Laws (Hons) dissertation, The University of Auckland.
22. ASA (2000a) ‘The impact of parallel importing on consumer law’.
23. RMI (2000) ‘The impact of parallel importing on consumer law’.
24. Maling N. (2000) ‘Government orders drug ad review’, Sunday Star Times, 8 October, A4.
25. Lambie D. (2001) Ministry of Health Report: DTC Advertising of Prescription Medicines. Policy Options. 14 August, Ministry of Health, Wellington. On-line release accessed via: http://www.executive.govt.nz/minister/king/dtca/01.htm.
26. ASA (2000a) Ministry of Health Report: DTC Advertising of Prescription Medicines. Policy Options.
27. ASA (2000a) Ministry of Health Report: DTC Advertising of Prescription Medicines. Policy Options.
28. Wechsler J. (2000a) ‘Health plan and payers attack DTC advertising, seek objective information on medication value’, Formulary, July, 616–17.
29. RMI (2000) Formulary
30. Pharmac (2000) http://www.pharmac.co.nz, accessed 16/10/2000.
31. Pharmac (1999) Annual Revietv http://www.pharmac.co.nz, accessed 16/10/2000.
32. Mold F. (2000) ‘Drugs debate a bitter pill’, N.Z. Herald, 19 October, A19.
33. Chi J. (1999) ‘Outlook for generic industry mixed: some pluses, minuses’, Drug Topics, 143(8), 19 April, 90–2.
34. MacKay P. Drug Topics.
35. Ministry of Health (1999) NZ Food: NZ People. Key Results of the 1997 National Nutrition Survey. Ministry of Health, Wellington.
36. University of Waikato (1997) An investigation Into The Consumer Market. University of Waikato. Hamilton, New Zealand.
37. Wilhelm C. (2000) ‘Growing the market for anti-obesity drugs’. CMR Focus, 15 May. 23–4.
38. RMI (2000) CMR Focus.
39. Gray R. (2000) ‘Lifestyle drugs as brands’. Campaign, 3 March. S12.
40. Goldberg R. (1999) ‘Ten myths about the market for prescription drugs’, Policy Report No. 230, October 1999. National Centre for Policy Analysis. www.ncpa.org/studies. accessed 27/10/2000.
41. Lichtenberg F. R. (1996) ‘Do (more and better) drugs keep people out of hospital?’, Health Economics, 86(2), May, 384–8.
42. Wilkes M. S. Bell R. A. Kravitz R. L. (2000) ‘Direct to consumer prescription drug advertising: trends, impacts and implications’, Health Affairs, 19(2), 110–28.
43. Johnson C. L. Ramaprasad A. Health Affairs.
44. MacKay P. Health Affairs.
45. Kravitz R. L. Bell R. A. Franz C. E. (1999) ‘A taxonomy of requests by patients: a new system for understanding the clinical negotiation in office practice’, Journal of Family Practice, 48(11), 872–78.
46. Hodnett J. (1995) ‘Targeting consumers’, Medical Marketing and Media, November, 91–5.
47. Ukens C. (1999) ‘What would make non-compliant patients more compliant?’, Drug Topics, 19 April 46-7.
48. Petersen C. (1999) ‘If you want to help asthma patients, treat their minds’, Managed Healthcare, April, 40–3.
49. Mordock G. (2000) ‘The future of customer relationships’, Pharmaceutical Executive, August, 114–5.
50. Walker J. (1996) ‘Drug giants build direct techniques’, Marketing Week, March 1, 23–24.
51. Anonymous (2000a) ‘Time Inc. survey on DTC highlights pharmacists' role’, Drug Store News, 14 August, 44.
52. Anonymous (2000a) ‘Time Inc. survey on DTC highlights pharmacists' role’, Drug Store News, 14 August, 44.
53. Wechsler J. (2000b) ‘Advertising under attack’, Pharmaceutical Executive, July, 26–34.
54. Dickinson J. C. (2000) ‘How DTC ads challenge the Rx legend’, Medical Marketing and Media, August, 12–13.
55. Bitter C. (2000) ‘Super brands, yes, but sustainable?’, Brandtveek, 19 June, 38–9.
56. Wilkes, et al Brandtveek.
57. Spurgeon D. (1999) ‘Doctors feel pressured by direct to consumer advertising’, British Medical Journal – online. BMJ, 319, (20 November), www.bmj.com, accessed 30/10/2000.
58. Spurgeon D. (1999) ‘Doctors feel pressured by direct to consumer advertising’, British Medical Journal – online. BMJ, 319, (20 November), www.bmj.com, accessed 30/10/2000.
59. Levy S. (1999) ‘DTC ads prompting mature consumers to visit the doctor’. Drug Topics, February, 21.
60. Liebman M. (2000) ‘Three scenarios for direct to success advertising’, Medical Marketing and Media, April, 72–6.
61. Sibley C. E. (2000) ‘Can't we get better DTC advertising research?’. Medical Marketing and Media, February, 96–100.
62. Royal New Zealand College of General Practitioners (2000) ‘General practitioners have welcomed the minister of health's decision to review direct-to-consumer (DTC) advertising’. Press Release, 9 October 2000.
63. MacKay P. Press Release.
64. Weissman R. X. (1998) ‘But first, call your drug company’, American Demographics, 27–30.
65. Bell R. A. Wilkes M. S. Kravitz R. L. (1999) ‘Advertisement induced prescription drug requests: patients' anticipated reactions to a physician who refuses’. Journal of Family Practice, 48(6), June, 446–52.
66. Peltier J. W. Westfall J. (2000) ‘Dissecting the HMO-benefsts manager relationship: what to measure and why’, Marketing Health Services, Summer, 5–13.
67. Levins I. (1998) ‘One-on-one relationship marketing’. Medical Marketing and Media, June, 45–52.
68. McCarthy R. (1998) ‘The price you pay for the drug not taken’, Business and Health, October, 27–33.
69. Liebman M. (1998) ‘DTC programs spur compliance’, Medical Marketing and Media, November, 58–61.
70. Ukens C. Medical Marketing and Media
71. Ukens C. Medical Marketing and Media
72. Levins I. Medical Marketing and Media
73. Peterson C. Medical Marketing and Media
74. Ukens C. Medical Marketing and Media
75. McCarthy R. Medical Marketing and Media
76. Angell M. (2000) ‘The pharmaceutical industry – to whom is it accountable?’, The New England Journal of Medicine, 342(25), 22 June, 1902-4.
77. Nelson P. (1974) ‘Advertising as information’, Journal of Political Economy, 82, July/August, 729–54.
78. Rubin P. (1997) ‘Information regulation (including regulation of advertising)’, available http://www.encyclo.findlaw.com, accessed 21/2/2000.
79. Matthews M. (2000) ‘Drug prices: a solution’, Barron's, 18 September, 60.
80. Matthews M. (2000) ‘Drug prices: a solution’, Barron's, 18 September, 60.
81. Danzon P. (2000) ‘Making sense out of drug prices’, Regulation, 23(1), 56–63.
82. Danzon P. (2000) ‘Making sense out of drug prices’, Regulation, 23(1), 56–63.
83. Institute of Chartered Accountants of New Zealand (1999) New Zealand Accounting Standards No. FRS-13 Accounting for Research and Development Costs, Institute of Chartered Accountants of New Zealand, Wellington.
84. Hooks J. (1995) ‘Research and development costs’, Chartered Accountants Journal, April, 40–3.
85. Goldberg R. Chartered Accountants Journal.
86. Wechsler J. (2000c) ‘War on drugs attacks high prices‘, Pharmaceutical Technology, June, 14–22.
87. Matthews M. Pharmaceutical Technology.
88. Danzon P, Pharmaceutical Technology.
89. Pharmaceutical Research and Manufacturers of America (PH RMA) (2000) ‘Why do prescription drugs cost so much?, http://www.phrma.org, accessed 31/10/2000.
90. Licking E. (2000) ‘A Pharma star is born?’, Business Week, 25 September pp. 100–108.
91. Lowes R. (2001) ‘Doctors and the Web: are on-line pharmacies good for your patients – and for you?’, Medical Economics, 5 June pp. 77–86.
92. Anonymous (2000b) ‘Are doctors who affiliate with internet pharmacies asking for trouble?’, Medical Economics, 7 August, p. 33.
93. Goetz J. Lund D. (2000) ‘What the law allows’, Pharmaceutical Executive, August pp. 76–84.
94. Ministry of Health (2000) ‘New regulations controlling Internet drug sales’, Media Release 2 November, 2000.
95. Advertising Standards Association (2000b) Proposal for Self-Regulation of Internet Marketing, http://www.asa.co.nz/proposal.htm, accessed 7/9/2000.
96. Medicines Act (1981) Proposal for Self-Regulation of Internet Marketing.
97. New Zealand Bill of Rights Act (1991)) New Zealand Bill of Rights Act.
98. ASA (2000a) New Zealand Bill of Rights Act.
99. MacKay P. New Zealand Bill of Rights Act.
100. RMI (2000) New Zealand Bill of Rights Act.
101. MacKay P. New Zealand Bill of Rights Act.
102. Wilkes, et al New Zealand Bill of Rights Act.
103. Sibley C. E. New Zealand Bill of Rights Act, p. 10.
104. Wechsler J. New Zealand Bill of Rights Act.